Todd Harrison argues 2026 midterms and DEA rescheduling will drive cannabis sector consolidation and profitability.
Summary
Todd Harrison argues that the 2026 midterm elections defeated prohibitionist efforts in states like Massachusetts and Idaho, while opening new markets in Pennsylvania and Wisconsin. He anticipates a positive DEA decision to reschedule cannabis from Schedule I to Schedule III, which would restore IRS Section 280E tax deductions and significantly improve company profitability. Harrison identifies the December 11th intoxicating hemp ban as a catalyst that will drive consumers back to regulated dispensaries. He expects 2027 to be a 'show me year' for double-digit growth as the market consolidates around fewer, larger players. Harrison highlights Village Farms and TerrAscend as undervalued opportunities relative to peers like Aurora.
Episode sections
- 0:07 – 2:48
Midterm Election Impact on Cannabis
Todd Harrison discusses the positive outcomes of the 2026 midterms for the cannabis industry, noting that prohibitionist efforts were defeated in key states like Massachusetts and Idaho. He highlights Pennsylvania and Wisconsin as potential new markets for legalization and notes that anti-cannabis senators in states like Iowa, South Carolina, and Maine were replaced by pro-legalization candidates.
- 2:48 – 5:39
Federal Rescheduling and 280E Tax Implications
The speakers discuss the pending DEA decision on rescheduling cannabis from Schedule I to Schedule III, referencing a six-week stay requested by the petitioner, referred to as 'Orange Julius.' Harrison expects a positive ruling soon, which would lift stays and potentially allow medical rescheduling to take effect immediately, while adult use rescheduling might have a 25-day stay. He notes that if rescheduling occurs, IRS Section 280E tax deductions could be restored, significantly impacting company profitability.
- 5:39 – 15:43
Intoxicating Hemp Ban and Market Consolidation
Harrison points to the December 11th enforcement of the intoxicating hemp ban as a major catalyst, potentially creating carve-outs for low-dose beverages. He argues this will drive consumers back to regulated dispensaries, boosting top-line growth. He believes 2027 will be the 'show me year' for the sector, with double-digit growth expected as the market consolidates and fewer, larger players emerge.
- 15:43 – 26:40
Company Specifics: Village Farms and TerrAscend
Harrison identifies Village Farms (VFF) as undervalued compared to peers like Aurora (ACB), citing its international presence and EU GMP certification. He also discusses TerrAscend (TER), noting it is currently unanalyzed due to ongoing acquisitions but is positioned to become the largest cannabis company globally, trading at a significant discount to peers once its roll-up strategy is complete.
Claims worth verifying
Massachusetts voters rejected a repeal of adult-use cannabis by a margin of over 70% (estimated 75-25).
Todd Harrison ·12:03
How to verify: Check official election results for the Massachusetts 2026 General Election ballot question regarding adult-use cannabis repeal.
Idaho voters rejected a constitutional amendment that would have prohibited citizen-led initiatives.
Todd Harrison ·1:05
How to verify: Check official election results for the Idaho 2026 General Election ballot measure regarding citizen-led initiatives.
The DEA has requested a six-week stay on the cannabis rescheduling decision, with a response expected by November.
Todd Harrison ·3:38
How to verify: Review Federal Register notices or DEA announcements regarding the administrative law judge's decision and any subsequent stays requested by the petitioner.
Medical cannabis rescheduling becomes effective the same day it is published in the Federal Register, whereas adult use may have a 25-day stay.
Todd Harrison ·4:26
How to verify: Review the final rule text published in the Federal Register for specific effective date clauses for medical vs. adult-use rescheduling.
The intoxicating hemp ban takes effect on December 11th.
Todd Harrison ·5:39
How to verify: Check the final rule or enforcement guidance issued by the FDA or DEA regarding the ban on intoxicating hemp products.
Village Farms (VFF) trades at approximately 4x EBITDA, while Aurora Cannabis (ACB) trades at 17x EBITDA.
Todd Harrison ·16:11
How to verify: Calculate the Enterprise Value to EBITDA multiple for VFF and ACB using current stock prices and trailing twelve-month financial data from company filings.
TerrAscend (TER) is acquiring companies at strike prices over twice its current stock price.
Todd Harrison ·18:43
How to verify: Review TerrAscend's press releases and SEC filings for recent acquisition agreements to compare strike prices to the stock price at the time of announcement.
Trump is resolute about rescheduling cannabis and is getting it done, regardless of congressional control.
Todd Harrison ·22:11
How to verify: Review public statements from the Trump administration or the DEA regarding the timeline and intent for cannabis rescheduling.
Glasshouse listed on the NYSE and is down 85% from its listing price.
Todd Harrison ·21:18
How to verify: Check historical stock price data for Glasshouse Biosciences (GHB) on the NYSE from its listing date to present.
Cantrust listed on the NYSE and had fake rooms (fraudulent operations).
Todd Harrison ·21:11
How to verify: Review SEC enforcement actions or news reports regarding Cantrust Cannabis Corp's listing and subsequent delisting or fraud allegations.
Do your own research
- Verify the official election results and margins for the Massachusetts and Idaho cannabis-related referendums.
- Check the DEA's official docket for the status of the cannabis rescheduling petition and any subsequent rulings after the six-week stay.
- Review IRS guidance and legal analyses regarding the potential restoration of Section 280E tax deductions if cannabis is rescheduled to Schedule III.
- Confirm the specific regulatory text and enforcement timeline for the intoxicating hemp ban effective December 11th.
- Analyze the latest 10-K and 10-Q filings for Village Farms (VFF) and Aurora (ACB) to verify current EBITDA multiples and international operations.
- Review TerrAscend's (TER) recent acquisition announcements and press releases to verify the strike prices relative to their stock price at the time of announcement.
- Research the content and findings of the GAO report referenced by the petitioner in the DEA rescheduling case.
Full transcriptexpand
- 0:07
- Unidentified speaker: Following a decisive midterm sweep, Cannabis has fresh momentum at the ballot box, raising new questions about legalization, the future of the industry, and whether the political progress can translate into gains on Wall Street.
- 0:17
- Unidentified speaker: Todd Harrison joins us to short through what matters, what might already be priced in, and what investors should be watching next on today's Alpha Nooner.
- 0:24
- Unidentified speaker: Todd, thanks so much for joining us to help us kind of break down, digest, and you know, sort through what matters.
- 0:29
- Unidentified speaker: Yeah, it's been an act of 24 hours.
- 0:31
- Unidentified speaker: Um, uh, but I think all in all, the way the election uh uh landed, uh, I mean, you there's obvious takeaways from a broader political spectrum, uh, but focused on our uh little corner of the universe.
- 0:46
- Unidentified speaker: Uh, I think it's widely agreed that this was a very positive uh election cycle for the cannabis industry on a few fronts.
- 0:54
- Unidentified speaker: Uh there's the obvious, right?
- 0:55
- Unidentified speaker: Massachusetts overwhelmingly rebuked uh repealing adult use, uh, even by a much wider margin than they initially enacted it.
- 1:04
- Unidentified speaker: So that was good.
- 1:05
- Unidentified speaker: Uh I know Idaho, which is uh sort of the uh uh you know the poster boy for uh anti-cannabis, uh, they rejected a constitutional amendment that would have uh prohibited citizen-led initiatives.
- 1:19
- Unidentified speaker: So, you know, you had a couple of um potential negatives uh um averted.
- 1:25
- Unidentified speaker: Um the more uh I think uh direct benefit for the cannabis industry, uh I see really centering in two states, Pennsylvania, where I feel like this will be the year.
- 1:37
- Unidentified speaker: And I've started to see some uh some opinions come out in that regard.
- 1:42
- Unidentified speaker: Uh that's been a long time coming.
- 1:45
- Unidentified speaker: And Wisconsin is suddenly on the board.
- 1:47
- Unidentified speaker: Uh the Badgers, uh the cheeseheads.
- 1:51
- Unidentified speaker: Uh so that looks like that could be a new state uh that answers the lexicon.
- 1:55
- Unidentified speaker: There's obviously others.
- 1:57
- Unidentified speaker: Uh Texas is one where I think you're gonna get a lot more movement there.
- 2:02
- Unidentified speaker: Um, I know that we didn't get the Senate, we meaning uh the pro-cannabis world, but uh I feel like a lot of those prohibitionists who said, um, you know, this is where I stand on on THC, and uh if you don't like it, vote me out.
- 2:18
- Unidentified speaker: They all got voted out.
- 2:19
- Unidentified speaker: Uh so be careful for what you wish.
- 2:22
- Unidentified speaker: Um away from that, um, Iowa, again, uh another state that uh hasn't been on anybody's radar.
- 2:30
- Unidentified speaker: Um the for this is their first governor, I think, coming in who uh has backed uh adult use.
- 2:36
- Unidentified speaker: Uh and then you have states like South Carolina and Maine uh electing senators for the first time who support uh federal cannabis legalization.
- 2:45
- Unidentified speaker: So there's a lot to point at.
- 2:48
- Unidentified speaker: Uh, I think the unknown, at least for me, uh, is what does the down what do the Democrats do with both uh chambers of uh Congress?
- 2:59
- Unidentified speaker: Um I mean they saw Trump steal this issue and reschedule it.
- 3:02
- Unidentified speaker: Do they try to one-up them and pass comprehensive legalization?
- 3:06
- Unidentified speaker: Um and uh if they do, what does that look like?
- 3:11
- Unidentified speaker: Um and number two, um, you know, does anything uh get done or is anything able to get done uh in in this environment and political climate?
- 3:23
- Unidentified speaker: So we don't know on that.
- 3:24
- Unidentified speaker: Uh, but you would think uh particularly if rescheduling goes through uh the stay lifts, uh we're recording this Wednesday afternoon.
- 3:31
- Unidentified speaker: We uh so tomorrow, I guess so the stay lifts today for everybody watching on Thursday.
- 3:37
- Unidentified speaker: Sure.
- 3:38
- Unidentified speaker: Uh and um, you know, we're expecting uh a response by uh Orange Julius by uh, you know, sometime uh I mean I think November, but I think it I don't think we're gonna have to wait long.
- 3:51
- Unidentified speaker: Um I one of the insiders I spoke with recently said that he actually framed that six uh six-week stay as a blessing in disguise.
- 4:01
- Unidentified speaker: Uh, you know, so Julius has been working on the brief throughout, and he just has to sort of tweak it uh to uh uh fit in this GAO report uh for the record.
- 4:12
- Unidentified speaker: And then we should get a ruling shortly thereafter.
- 4:15
- Unidentified speaker: We are expecting a positive ruling.
- 4:17
- Unidentified speaker: Uh, and then uh, you know, we'll see how quickly, you know, it moves uh on whether or not you know you have the automatic 25-day stay period.
- 4:26
- Unidentified speaker: But for medical, uh, they made it effective the same day they published it in the Federal Register.
- 4:31
- Unidentified speaker: I don't know if the same standard applies uh for adult use.
- 4:35
- Unidentified speaker: Um I honestly don't have an idea.
- 4:37
- Unidentified speaker: Uh, but uh there is a pathway that this can become effective in 2026.
- 4:43
- Unidentified speaker: If it doesn't, uh we can expect Treasury guidance to contemplate that uh in their guidance for our for 280e.
- 4:52
- Unidentified speaker: Um and if they are gonna vacate it back to 2023, it makes you know no shit's difference for 2027 plus 2026 and onward.
- 5:00
- Unidentified speaker: Uh if this drags in.
- 5:01
- Unidentified speaker: But I don't know if it will.
- 5:03
- Unidentified speaker: Um, I know um cavalchi odds up at about 5% right now that it's gonna pass.
- 5:09
- Unidentified speaker: Who knows?
- 5:10
- Unidentified speaker: Uh, but but but but I think you know if it bleeds into Q1, uh, you know, you're still gonna get the benefits of the 280E back uh backdated to uh you know through 2026.
- 5:22
- Unidentified speaker: So um that's exciting because you know it it's uh it's it's been a long time coming.
- 5:29
- Unidentified speaker: Um but I think taken in concert the election and the rescheduling process and medical already being rescheduled.
- 5:39
- Unidentified speaker: Uh we have the um the intoxicating hemp ban, importantly, uh coming into play on December 11th.
- 5:47
- Unidentified speaker: There's a lot of chatter that there's gonna be some sort of beverage carve out.
- 5:50
- Unidentified speaker: I don't know, uh, I don't know from that, but I that is what the word is.
- 5:54
- Unidentified speaker: I saw right before we came on today that um total wine uh is is is is is pushing more chips into the table to try to get that done.
- 6:04
- Unidentified speaker: Um but it remains to be seen, uh obviously.
- 6:08
- Unidentified speaker: I mean, we're gonna have a new Congress, so if it doesn't get done uh by the lame duck, you know, you can expect something in uh you know in the new in the 120th Congress.
- 6:20
- Unidentified speaker: I mean, this has been going on some time now.
- 6:22
- Unidentified speaker: Um, but the 120th Congress, maybe they get something done, we'll see.
- 6:26
- Unidentified speaker: But regardless, at the state level, I think uh it's hard to see uh uh the election outcome through the eyes of cannabis is anything less than uh friendly uh and incremental, whether that's just Pennsylvania and Wisconsin, or if that includes a program that's a little bit more robust in Texas, if it includes some of these states like South Carolina, uh, you know, there's a lot of there's a lot of movement at the state level.
- 6:55
- Unidentified speaker: Uh, and I think that's only gonna, you know, uh uh accelerate when we see Schedule III pass.
- 7:01
- Unidentified speaker: Yep.
- 7:02
- Unidentified speaker: No, I think that's that summarizes it very, very well.
- 7:04
- Unidentified speaker: I do think just from midterms, like you're saying, I think was trying to look as I was prepping, kind of combing through stuff for something that kind of balanced out the view of saying, was there anything negative kind of from a cannabis perspective following the midterms and really couldn't find anything.
- 7:16
- Unidentified speaker: I feel like obviously, like you mentioned, some key elements states-wise, uh, you know, the Trafecta in Pennsylvania, Wisconsin, like you mentioned, even I think you're right, Idaho, which obviously lesser to some degree because it is not a huge proponent of cannabis, but just kind of upholding against kind of that prohibitionist view, or I guess kind of ultimately robbing, I guess, voters of their ability to potentially in the future put up something.
- 7:37
- Unidentified speaker: Uh, I think that also applied to psychedelics as well.
- 7:39
- Unidentified speaker: And it'll be interesting to see how the composition of the Congress comes out.
- 7:43
- Unidentified speaker: Because as I said, South Carolina and Maine have first-time senators who are who are pro-cannabis legalization.
- 7:49
- Unidentified speaker: So um it'll be interesting to see when the map comes out to have um, you know, just have a comprehensive look at, you know, where everybody stands on this.
- 7:59
- Unidentified speaker: You know, the risk.
- 8:01
- Unidentified speaker: Oh, I can't really say it like that, but the unknown is, you know, what exactly it looks like, right?
- 8:08
- Unidentified speaker: I mean, there's uh presumably a different flavor of legalization, uh, whether it's coming from the Republicans or the Democrats, in terms of just how that looks and feels, right?
- 8:21
- Unidentified speaker: Um, so like we'll see, right?
- 8:25
- Unidentified speaker: I mean, I and forgive me for you know saying to Senator Schumer and Senator Booker and Hakeem Jeffries, like, you know, show us, you know, show us because you know, I before these two years, we spent four years getting jerked around by the Democrats with broken promises and and and it just was not productive.
- 8:45
- Unidentified speaker: Yep.
- 8:46
- Unidentified speaker: So we'll see what happens.
- 8:47
- Unidentified speaker: I think that's true.
- 8:48
- Unidentified speaker: Although, again, I'm hoping, and I don't know if it's my own bias, I guess, ultimately, but I feel like with cannabis, it has been increasingly just gaining momentum in terms of being in the conversation, in terms of normalization, all these things.
- 8:59
- Unidentified speaker: But I think it is basically this is to me, sort of proof of hitting that tipping point of I know it's been back and forth, I know it's been partisan in a lot of ways, but I think it is kind of clearing that finally in some way.
- 9:09
- Unidentified speaker: Um, again, you're right, we have to wait and see.
- 9:11
- Unidentified speaker: Um, but I I do really hope that we finally kind of cleared some of the craziness, I think, within cannabis and people just want sort of a common sense, you know, thing in place, I think, for people.
- 9:20
- Unidentified speaker: So no, I mean, listen, the setup is there.
- 9:22
- Unidentified speaker: I mean, we've been pretty consistent that we think we get a uh a recommendation, if not a rescheduling by this year.
- 9:30
- Unidentified speaker: I know that last part is kind of people laugh and say, Well, no, you need 30 days after, maybe.
- 9:35
- Unidentified speaker: I mean, they didn't for medical, but you know, we'll see.
- 9:39
- Unidentified speaker: You know, entering new year, the new year, you have new Congress.
- 9:43
- Unidentified speaker: And uh, you know, I think the state mandates are gonna you're gonna start to see.
- 9:47
- Unidentified speaker: It's been a couple of years.
- 9:48
- Unidentified speaker: I mean, it's been a couple cycles, I should say, since we've seen real reform on the ballot, you're right.
- 9:54
- Unidentified speaker: There hasn't been new states flipped in a while, right?
- 9:57
- Unidentified speaker: I mean, Virginia's still waiting to to pop.
- 10:00
- Unidentified speaker: So um, I do feel like there's going to be uh more of a top-line story to talk about, but I don't think two states are going to necessarily drive that conversation.
- 10:11
- Unidentified speaker: I think it's the intoxicating hemp ban that's going to drive that conversation.
- 10:16
- Unidentified speaker: Okay.
- 10:16
- Unidentified speaker: And I do think there's a a way to get, you know, low-dose beverages and perhaps low-dose gummies, you know, five milligrams a pop, like, okay, uh, as long as it's regulated and all that, like, great.
- 10:31
- Unidentified speaker: But I don't, you know, I still think hemp is industrial use.
- 10:34
- Unidentified speaker: And if it gets you high, it's cannabis.
- 10:36
- Unidentified speaker: And that doesn't change because we have a new, you know, party in town.
- 10:40
- Unidentified speaker: Um, but but I do think that the hemp ban, the intoxicating hemp ban, I think edibles and inhalables, I think edibles, but I'm sure inhalables are are are going to be done with.
- 10:53
- Unidentified speaker: And and that's gonna, you know, a certain delta that's gonna help drive top line growth in the regulated market.
- 10:58
- Unidentified speaker: So you have a few uh cross currents that are aligning, but you know, if there's a definition of a show me sector at, you know, after this long of a bear market, I think, I think we're there.
- 11:10
- Unidentified speaker: Yep, a thousand percent.
- 11:11
- Unidentified speaker: Nice pun on uh Delta as well.
- 11:13
- Unidentified speaker: I am curious in terms of the Massachusetts side of the story.
- 11:16
- Unidentified speaker: I feel like there's been so much focus there.
- 11:18
- Unidentified speaker: I feel like I've seen some of the prohibitionists kind of be vocal about saying this is a win because it was on, you know, up for a debate.
- 11:23
- Unidentified speaker: Again, I think pretty crushingly decided that you know, people who are in Massachusetts want to maintain their legal market and all these things.
- 11:30
- Unidentified speaker: I'm curious in your thoughts of you know, how much does this do to kind of defang future prohibitionist pushes in terms of fundraising anything?
- 11:37
- Unidentified speaker: I don't know what your thoughts are.
- 11:38
- Unidentified speaker: I mean, as long as there's money to be spent against these things.
- 11:43
- Unidentified speaker: I mean, Sam isn't bankrolling themselves, somebody's somebody is you know paying their bills, and they're gonna, you know, they're gonna keep going as long as somebody continues to pay them.
- 11:53
- Unidentified speaker: But to your point, I think it, you know, if it was even if it was like 6040, we're gonna keep it, that would have been a huge loss, uh, you know, a Pyrrhic victory, if you will.
- 12:01
- Unidentified speaker: But it was pretty overwhelming.
- 12:03
- Unidentified speaker: I think it was like 7525.
- 12:05
- Unidentified speaker: Yeah, something like that.
- 12:06
- Unidentified speaker: Something like that.
- 12:06
- Unidentified speaker: Over 70 for sure.
- 12:07
- Unidentified speaker: Yeah.
- 12:09
- Unidentified speaker: So you know, you know, what does that tell you?
- 12:12
- Unidentified speaker: But again, like go go back to the story, like THC use and and normalization and adoption over the last decade has been up and to the right, like no doubt, right?
- 12:23
- Unidentified speaker: It's just been it's been bifurcated into a couple of channels.
- 12:26
- Unidentified speaker: So presumably, as those channels merge, uh, or one of them goes away, uh, yes, you will see an uptick in the illicit market again, which was operating under the guise of intoxicating hemp.
- 12:39
- Unidentified speaker: But you know, at this point, and given the way the price uh prices have been moving, you know, it it just makes more sense to get product from a licensed dispensary that you know isn't you know poisoned and filled with uh you know intoxicants.
- 12:56
- Unidentified speaker: So or or I should say uh you know, pesticides and other toxic uh you know uh uh inputs.
- 13:04
- Unidentified speaker: But I think we know that already.
- 13:07
- Unidentified speaker: So you know, like I said, 2027, I think will be the show me year.
- 13:11
- Unidentified speaker: Uh there should be some real top line growth.
- 13:14
- Unidentified speaker: Um, and you know, and I know we're you know in the thick of of of earnings right now, and you know, how are they that they're fine for what they are, right?
- 13:22
- Unidentified speaker: I mean, um, yeah, three, four percent top line growth is a lot better than a negative curve, but it's not gonna really, it's not gonna really sorry, it's not gonna really drive you know growth investors to pile into the sector.
- 13:38
- Unidentified speaker: Like you start seeing double digit growth come back next year and you know, we're consolidation, we have fewer, fewer larger players, you know, I think the space, you know, becomes investable again.
- 13:49
- Unidentified speaker: Yep.
- 13:50
- Unidentified speaker: No, I think that makes uh perfect sense.
- 13:51
- Unidentified speaker: In terms of what we've seen so far from earnings, has anything stood out to you?
- 13:54
- Unidentified speaker: I feel like have been trying to keep an eye on, you know, has there been any pull from states that have been cracking down on sort of the wider range of intoxicating ham?
- 14:03
- Unidentified speaker: Again, I kind of too hope that uh players who are in that space who are playing by the rules in their own space do ultimately able are able to transition into kind of playing in the same pool by the same rules, although the same thing, uh, in sort of the legal cannabis space at some point.
- 14:16
- Unidentified speaker: Um, but I think you know, we have seen some conversion over which has been helpful.
- 14:19
- Unidentified speaker: Is there anything else that you've been kind of keeping an eye on?
- 14:21
- Unidentified speaker: What's been kind of interesting to pull out?
- 14:24
- Unidentified speaker: No, I mean, listen, it it there's the whole DEA registration process has been interesting to watch.
- 14:31
- Unidentified speaker: Although I get the sense that they are phasing their way through this as opposed to like having a giant read-through from that one dispensary in Minnesota.
- 14:40
- Unidentified speaker: I think inversion is a problem.
- 14:42
- Unidentified speaker: I think California is going to be an interesting case.
- 14:44
- Unidentified speaker: But as my friend Graham tells me, that's about the dispensaries, not about the the uh operators or the growers.
- 14:50
- Unidentified speaker: Um, nothing really has jumped out uh new or exciting that made me, you know, stop in my tracks and go, wow.
- 15:01
- Unidentified speaker: Um, I am looking forward to some reports that are still coming up.
- 15:04
- Unidentified speaker: Again, you know, we're recording this Wednesday, it'll be Thursday.
- 15:07
- Unidentified speaker: So by the time this airs, we'll have True Leave out, which is tomorrow morning or this morning, depending on how you want to look at this.
- 15:14
- Unidentified speaker: Uh and you know, as we were sitting here getting ready to go on, we saw Green Film come out and it looked like a top line B, uh marginally better on Ebada.
- 15:22
- Unidentified speaker: Um, and that call is at five o'clock tonight after after we're wrapped here.
- 15:27
- Unidentified speaker: Um, so you know, Green Thumb, True Leave, those are some big names.
- 15:31
- Unidentified speaker: Um, and then you know, next week I can tell and Terracent, I think is tomorrow night.
- 15:35
- Unidentified speaker: Uh JW and uh and Ziod, who I continue to think are amongst the best operators out there, uh, if you look at their numbers.
- 15:43
- Unidentified speaker: Um I'm excited to see what Village Farms has to say on Monday.
- 15:46
- Unidentified speaker: You know, this whole Aurora OGI Cure Leaf uh trifecta um screams to me that Village Farms is undervalued, even more so than it did before that started, because we've been talking about this for the better part of you know four or five months now.
- 16:02
- Unidentified speaker: Um, you know, Village to me is everything you want to be in more in an international cannabis company.
- 16:08
- Unidentified speaker: Um, and I think they're extremely well positioned.
- 16:11
- Unidentified speaker: And if Aurora is worth, I think it's like what, 17 times Ibada, and Village is trading like four times, and I arguably Village arguably is a much better company.
- 16:21
- Unidentified speaker: I think they have the best management team, the deepest bench, and the most optionality.
- 16:26
- Unidentified speaker: Uh, but you know, we'll see what they we'll see how they print on Monday, right?
- 16:32
- Unidentified speaker: Um, you know, the stock acts great.
- 16:34
- Unidentified speaker: I think, you know, as people start to put together the value of EU GMP certification from source, but I think that the stock, again, this was a 20 $20 stock in 2020.
- 16:45
- Unidentified speaker: It's you know, it just rallied 50% at three.
- 16:50
- Unidentified speaker: Right.
- 16:50
- Unidentified speaker: So, like, I don't I don't think it's over by any long shot for that uh company.
- 16:55
- Unidentified speaker: Somebody I saw on Twitter says, why don't they get bought out?
- 16:58
- Unidentified speaker: Like, no, thank you.
- 16:59
- Unidentified speaker: Like, I like this management team.
- 17:01
- Unidentified speaker: I think they're phenomenal, they're patient, they're they're aware, they're diligent, and they have integrity.
- 17:06
- Unidentified speaker: Like, you know, who's gonna buy them that's gonna give me as much confidence as as that management team does.
- 17:13
- Unidentified speaker: So, like, I have no problem with them going it alone.
- 17:15
- Unidentified speaker: I think they're gonna be one of the leaders, and I think they're gonna lead by example, but that's that's just my opinion.
- 17:20
- Unidentified speaker: That's true.
- 17:21
- Unidentified speaker: Although I guess you do hope if you do see some mergers or acquisitions, you do retain and kind of bring up some of the talent.
- 17:26
- Unidentified speaker: Obviously, thinking of of something like Virio and Sammy and Bruce, I feel like uh, you know, being able to retain that.
- 17:30
- Unidentified speaker: You can do that.
- 17:31
- Unidentified speaker: That's another one that people this gets lost in the sauce.
- 17:34
- Unidentified speaker: I mean, this is a company that people just don't understand.
- 17:38
- Unidentified speaker: There's no analysts cover it.
- 17:39
- Unidentified speaker: All the analysts we talked to don't want to cover it yet because they're still acquiring companies.
- 17:45
- Unidentified speaker: So, like, yeah, we'll do our modeling Q1 when you know when when Fluent and uh um uh um what was it in Vegas?
- 17:55
- Unidentified speaker: Uh 13.
- 17:57
- Unidentified speaker: 13, thank you.
- 17:58
- Unidentified speaker: And then they have other assets that they have to assimilate.
- 18:01
- Unidentified speaker: But when when they're done doing that, poker protecting math, this they're gonna be the biggest cannabis company in the world, and they're and people are gonna do the math and realize that they are trading at a like a five-term discount to any other cannabis company out there.
- 18:15
- Unidentified speaker: So, you know, that's one of those where like you have no annals coverage, like uh market's very thin, uh, but the math that's like an outlier, right?
- 18:27
- Unidentified speaker: It's just one of those like massive outliers in terms of the value of the company and the metrics versus the perception in the street or the the investor base.
- 18:38
- Unidentified speaker: Uh, meanwhile, they continue to roll up assets and everyone's like, oh, they're diluting down here.
- 18:43
- Unidentified speaker: But what a lot of people miss is you know, their their strike for these acquisitions is uh over two times where the stock price is now.
- 18:51
- Unidentified speaker: So it's you know, it's a little confusing if you're trying to do the math and do a value, you know, do a proper valuation.
- 18:57
- Unidentified speaker: But at the same time, it's you know, all these people saying they're diluting the hill are they investors, they're they're not actually, you know, they're not right.
- 19:07
- Unidentified speaker: So um, you know, they're picking up good assets.
- 19:09
- Unidentified speaker: Sammy and Bruce, I think strategically were terrific.
- 19:12
- Unidentified speaker: Um, but that but that's you know one of many, and they keep adding to their team.
- 19:16
- Unidentified speaker: So that's a very it's a it's a very interesting story to watch because people say, Oh, somebody should come in and consolidate these names.
- 19:23
- Unidentified speaker: I'm like, yeah, that's sort of happening already, right?
- 19:27
- Unidentified speaker: Like it just but but people don't want to, you know, like the more like our our names have had a good couple of days and then they're down a little bit this morning, and it's like, you know, my my switchboard lights up like there's a fire.
- 19:39
- Unidentified speaker: And it's like, you know, like we have a lot of wood to chop to get back to where we were, but let's not forget, like, we haven't gotten anything that we're expecting.
- 19:49
- Unidentified speaker: I mean, medical, yes, but when we get comprehensive uh 280 uh or rescheduling um and 280 removed, um, I think that the the trigger will be the treasury guidance and the IRS guidance because that's going to clean up a lot of questions around the balance sheet and and what you know these debt ratios look like, and then all of a sudden you're cooking with oil.
- 20:12
- Unidentified speaker: Not everybody, but but but some for sure.
- 20:16
- Unidentified speaker: Yeah, that's fair.
- 20:17
- Unidentified speaker: I am uh I I obviously volatility in cannabis in the cannabis space is kind of not surprising for anybody who's been following this space for a while now.
- 20:23
- Unidentified speaker: I think a bit probably disappointing for people to see some of the names read, I think, just on the screen today, especially following what I think is pretty comprehensively, you know, a strong sign for the industry.
- 20:32
- Unidentified speaker: Again, you're right that there are some key things that we're waiting on.
- 20:35
- Unidentified speaker: But again, those seem to be on track and in progress.
- 20:38
- Unidentified speaker: And I feel like they are questions that I imagine will get sorted soon.
- 20:42
- Unidentified speaker: Um, but what do you make of sort of that?
- 20:44
- Unidentified speaker: Like when you're talking with people, how do you kind of explain that story, explain the patience of it all without sort of sounding like obviously people have been patient for a long time?
- 20:51
- Unidentified speaker: Um, but things are, it feels like changing in a meaningful way.
- 20:55
- Unidentified speaker: How to kind of differentiate that from what we've seen in the past?
- 20:58
- Unidentified speaker: I mean, it it you know, you can't sugarcoat what what what's happened the last six years.
- 21:05
- Unidentified speaker: Um, you know, and every possible wart in this sector has been exposed.
- 21:11
- Unidentified speaker: And, you know, you know, I remember when Cantrust listed on the New York Stock Exchange and they had fake rooms.
- 21:18
- Unidentified speaker: I almost am reminded of Glasshouse because Glasshouse listed on New York Stock Exchange and is down 85%.
- 21:23
- Unidentified speaker: And it's like they had Wellington, and it's like that's not that doesn't, you know, inspire confidence in the sector, right?
- 21:31
- Unidentified speaker: So we have all these sort of self-inflicted wounds that we've been navigating on top of the structural, on top of what I think is the single biggest determinant of of the fate of our space, other than other than 280, uh, and other than it being federally illegal, you know, has been the intoxicating hemp market.
- 21:52
- Unidentified speaker: I mean, that's just that's just stolen half the growth.
- 21:55
- Unidentified speaker: I mean, it's almost as big as the regulator market.
- 21:58
- Unidentified speaker: So by you know, default, you could turn around and say that it took half the growth, right?
- 22:03
- Unidentified speaker: Um, from or if not all the growth from the space.
- 22:06
- Unidentified speaker: Uh, but we'll get some of that back.
- 22:08
- Unidentified speaker: And you know, good actors should get rewarded.
- 22:11
- Unidentified speaker: Um, you know, our people who we talk to who are close to the situation in DC said that Trump is resolute, he's getting this done.
- 22:20
- Unidentified speaker: Um, doesn't impact, it's not that's not impacted by you know the congressional uh uh you know landing spot.
- 22:28
- Unidentified speaker: But um it'll be interesting.
- 22:30
- Unidentified speaker: I mean, listen, you know, they he did steal the issue from the Dems.
- 22:34
- Unidentified speaker: Do the Dems try to, you know, you know, play leap prog and and and and decriminal and and re and deschedule it.
- 22:41
- Unidentified speaker: I don't know.
- 22:42
- Unidentified speaker: There has to be a congressional framework eventually for this product, right?
- 22:48
- Unidentified speaker: For this industry.
- 22:50
- Unidentified speaker: So hopefully, but like I don't trust any of those fuckers.
- 22:55
- Unidentified speaker: I will say, I feel like there have been quotes, like I'm thinking of you know Telarico, and I feel like his uh quotes he's been you know, uh quoted saying lately, like he's willing to work on those certain issues, cannabis, especially being one, and not necessarily trying to kind of steal the football.
- 23:09
- Unidentified speaker: Again, I mean, maybe it would be great in some ways, I guess, to you know get something done faster, but it seems like it's already in progress, it's already sort of getting done.
- 23:16
- Unidentified speaker: So and then he'll talk to Chuck Schumer and Corey Booker, who will lay himself down.
- 23:22
- Unidentified speaker: I just like there are other issues to be split on.
- 23:24
- Unidentified speaker: I don't know, all right?
- 23:25
- Unidentified speaker: I don't know.
- 23:26
- Unidentified speaker: I don't know.
- 23:27
- Unidentified speaker: Forgive me for being a little bit suspect of yeah.
- 23:31
- Unidentified speaker: I mean, these fuckers, you know, they lied through their teeth last time.
- 23:35
- Unidentified speaker: Yeah, fair enough.
- 23:36
- Unidentified speaker: Fair enough.
- 23:37
- Unidentified speaker: Um, all right.
- 23:37
- Unidentified speaker: Well, then I guess just sort of, you know, when you're talking with people and um uh you know, I just kind of looking at it now.
- 23:43
- Unidentified speaker: Anything that you are kind of thinking of, keeping in mind as we're heading into these kind of next few weeks that hopefully will be kind of kind of key to the gamerspace.
- 23:53
- Unidentified speaker: Yeah, I think we're gonna learn a lot.
- 23:54
- Unidentified speaker: Um, I think, you know, uh again, this is airing on Thursday.
- 23:58
- Unidentified speaker: So as of tonight, you know, it's uh the stays lifted.
- 24:02
- Unidentified speaker: You know, I'm not gonna come out and say that there'll be a decision the next day because that's a little aggressive, but I wouldn't, it wouldn't, I wouldn't fall over if there was or if it's next week.
- 24:12
- Unidentified speaker: But as long as it's before Thanksgiving, I think we're good.
- 24:14
- Unidentified speaker: And I think we'll get it before Thanksgiving.
- 24:17
- Unidentified speaker: Thanksgiving, Thanksgiving.
- 24:18
- Unidentified speaker: I know it's a big holiday, I think, for the industry.
- 24:21
- Unidentified speaker: So hopefully we get it then as well.
- 24:22
- Unidentified speaker: I mean, it's not that far, it's three weeks.
- 24:24
- Unidentified speaker: So I mean, I hope it's not, you know, I hope we're not sitting here, you know, tape watching into year end saying they got us again.
- 24:31
- Unidentified speaker: But I I just don't see it.
- 24:33
- Unidentified speaker: I mean, every all indications from the administration that they want to move this as fast as possible.
- 24:38
- Unidentified speaker: Um, and that's not that hasn't changed because they didn't get it done by the midterms.
- 24:43
- Unidentified speaker: That makes sense.
- 24:44
- Unidentified speaker: I do also wonder because I think I was going to talk about that when we were talking about at the beginning, is I feel like it used to be a conversation around this was a way to kind of win points during the midterms.
- 24:51
- Unidentified speaker: That feels like that got abandoned.
- 24:52
- Unidentified speaker: But ultimately, I feel like the what we've seen from the midterms in terms of cannabis specifically does give me confidence, hopefully, that it I don't think it got, I don't think that got deterred.
- 25:02
- Unidentified speaker: I think it just was the process.
- 25:04
- Unidentified speaker: And I think the ALJ judge made the decision and said, you know what?
- 25:09
- Unidentified speaker: If I don't admit, you know, if I don't admit this is part of the record, then you know, there's a legitimate um you know, beef if you appeal this, and then if it gets caught up in a in a stay after that, then we've you know, then that goes into purgatory, right?
- 25:25
- Unidentified speaker: So this way it it it addressed it, incorporated it, and you know, by all accounts, it it was literally a procedural kind of safeguard to make the the the rule more durable legally going forward.
- 25:39
- Unidentified speaker: And you know, if that's the price you have to pay to make it more durable, then so be it.
- 25:44
- Unidentified speaker: But I don't think, and you know, there were people within the administration who were talking to us a couple days before saying, like, yeah, this is definitely getting done, you know, ASAP, and then the state came out.
- 25:54
- Unidentified speaker: So I don't think they knew about it.
- 25:56
- Unidentified speaker: Um, I but I think it was a judgment call by Orange Julius to make it more durable.
- 26:02
- Unidentified speaker: Orange Julius.
- 26:02
- Unidentified speaker: What a nickname.
- 26:03
- Unidentified speaker: Um, okay.
- 26:04
- Unidentified speaker: Do we even know what Orange Julius is?
- 26:05
- Unidentified speaker: It's a drink, you know?
- 26:07
- Unidentified speaker: No, it's at the mall.
- 26:08
- Unidentified speaker: At the mall, they have right, right, right.
- 26:10
- Unidentified speaker: I don't know if they still have them or not.
- 26:11
- Unidentified speaker: The classics.
- 26:12
- Unidentified speaker: I think I worked there in high school for a hot minute.
- 26:14
- Unidentified speaker: Oh, what a dream.
- 26:15
- Unidentified speaker: That's awesome.
- 26:15
- Unidentified speaker: Uh, it all comes full circle in its own way.
- 26:17
- Unidentified speaker: All right.
- 26:17
- Unidentified speaker: Well then Todd, thanks so much as always.
- 26:19
- Unidentified speaker: Really appreciate you breaking it down.
- 26:20
- Unidentified speaker: I feel like there's such demand.
- 26:21
- Unidentified speaker: I mean, there always is a demand in cannabis to understand, you know, what's going on, what's moving, what actually makes a difference.
- 26:27
- Unidentified speaker: And again, I think uh breaking down kind of the midterms is key in that.
- 26:31
- Unidentified speaker: So really appreciate the time.
- 26:32
- Unidentified speaker: Hopefully, we'll be touching base soon-ish and have more to talk about.
- 26:35
- Unidentified speaker: Um, that should be good.
- 26:37
- Unidentified speaker: Other than that, thanks so much.
- 26:38
- Unidentified speaker: I'll let you go.
- 26:39
- Unidentified speaker: Have a good one.
More from AlphaNooner by AdvisorShares
AlphaNooner - A Veteran’s Journey Through Trauma & Psychedelic Medicine with Graham Ginn
Episode discussion: Veteran Graham Ginn discusses psychedelic medicine, trauma healing, and legislative advocacy for psilocybin research.
Speakers’ claims: Graham Ginn, a Navy veteran, shares his transition from skepticism to advocacy for psychedelic medicine after a transformative experience during a mental health crisis. He recounts using plant entheogens to cope with a stage four throat cancer diagnosis, claiming the substances aided in pain management and psychological resilience. Ginn highlights legislative efforts such as Texas HB 1802 and the federal Freedom to Heal Act as key vehicles for descheduling and research. The discussion emphasizes the importance of professional integration, medical screening for drug interactions, and the distinction between regulated therapy and unlicensed facilitation.
AlphaNooner - Cannabis Rescheduling & the Psychedelic Selloff: What Matters Now with Dan Ahrens
Episode discussion: Dan Ahrens argues cannabis rescheduling is an administrative process unaffected by election outcomes, while psychedelic stocks overreacted to Otsuka's NDA filing.
Speakers’ claims: Dan Ahrens discusses the recent Schwab Impact Conference, noting that cannabis rescheduling is an administrative process handled by the DOJ and Administrative Law Judges, making it immune to legislative stalemate in Congress. He highlights that the upcoming hemp ban is driving revenue growth for licensed dispensaries by capturing displaced market share. Regarding psychedelics, Ahrens argues the recent selloff following Otsuka’s New Drug Application (NDA) filing was an overreaction, as the nonprofit entity lacks commercial infrastructure and must navigate existing patents held by competitors like Compass Pathways. He also clarifies that cannabis ETFs using total return swaps can exceed 100% exposure without incurring margin debt or interest payments.